All Stories

  1. PCSK9 Inhibitors: Novel Therapeutic Strategies for Lowering LDLCholesterol

    Article • Mini-Reviews in Medicinal Chemistry, December 2018, Bentham Science Publishers

    Professor Zhaopeng Liu, Yan Wang

  2. Evaluation of WO2017018805: 1,3,4-oxadiazole sulfamide derivatives as selective HDAC6 inhibitors

    Article • Expert Opinion on Therapeutic Patents, August 2018, Taylor & Francis

    Professor Zhaopeng Liu

  3. Advances in the Total Synthesis of Lactonamycin

    Article • Current Organic Chemistry, May 2016, Bentham Science Publishers

    Professor Zhaopeng Liu

  4. Synthesis and Evaluation of Trehalose-Based Compounds as Novel Inhibitors of Cancer Cell Migration and Invasion

    Article • Chemical Biology & Drug Design, April 2015, Wiley

    Professor Zhaopeng Liu

  5. Tubulin Colchicine Binding Site Inhibitors as Vascular Disrupting Agents in Clinical Developments

    Article • Current Medicinal Chemistry, March 2015, Bentham Science Publishers

    Professor Zhaopeng Liu

  6. Developments of DNA-dependent Protein Kinase Inhibitors as Anticancer Agents

    Article • Mini-Reviews in Medicinal Chemistry, October 2014, Bentham Science Publishers

    Professor Zhaopeng Liu

  7. Developments of Kinesin Spindle Protein Inhibitors as Antitumor Agents Based on the Five-membered Heterocycle Scaffolds

    Article • Current Medicinal Chemistry, March 2014, Bentham Science Publishers

    Professor Zhaopeng Liu

  8. Recent Developments of Small Molecule PI3K/mTOR Dual Inhibitors

    Article • Mini-Reviews in Medicinal Chemistry, December 2013, Bentham Science Publishers

    Professor Zhaopeng Liu